InsidersTradesSigma
Total declarations
Company
▲ Purchases (44 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
44
Disclosed sells
0
T+90 hit rate
4%
T+90 mean return
-52.1%
Across 45 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Peyer James, Board Member. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. Cumulatively, 48 filings have been published. Split: 44 buys · 0 sell. Total volume traded: €2.3m. Activity tracked since 5 May 2021. The latest transaction was filed on 31 July 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations48 total
1,587,302 shares@ US$1.2643.9% of flowCommon StockSEC:0000897069-23-001052:0
4,466 shares0Common StockSEC:0001209191-23-042079:0
4,466 shares0Restricted Stock Unit GrantSEC:0001567619-22-014723:0
4,466 shares0Restricted Stock Unit GrantSEC:0001567619-22-012841:0
1,203 shares@ US$3.200.013% mcap0.1% of flowCommon StockSEC:0001567619-22-012647:0
Ideal exit: 27 Nov 2022 (T+270)
9,500 shares@ US$14.340.42% mcap4.9% of flowCommon StockSEC:0001567619-22-008804:0
Ideal exit: 18 Dec 2021 (T+270)
752 shares@ US$19.750.045% mcap0.5% of flowCommon StockSEC:0001567619-22-008802:0
Ideal exit: 15 Nov 2021 (T+270)
1,203 shares@ US$3.200.013% mcap0.1% of flowCommon StockSEC:0001567619-22-006006:0
Ideal exit: 27 Nov 2022 (T+270)
42 shares@ US$3.600.0005% mcap0.0% of flowCommon StockSEC:0001567619-22-005915:0
Ideal exit: 25 Nov 2022 (T+270)
2,500 shares@ US$3.650.030% mcap0.4% of flowCommon StockSEC:0001567619-22-005792:0
Ideal exit: 22 Nov 2022 (T+270)
2,500 shares@ US$3.800.031% mcap0.4% of flowCommon StockSEC:0001567619-22-005517:0
Ideal exit: 20 Nov 2022 (T+270)
4,949 shares@ US$4.170.066% mcap0.8% of flowCommon StockSEC:0001567619-22-005191:0
Ideal exit: 14 Nov 2022 (T+270)
10,000 shares@ US$4.180.13% mcap1.6% of flowCommon StockSEC:0001567619-22-004777:0
Ideal exit: 11 Nov 2022 (T+270)
5,000 shares@ US$4.580.073% mcap0.9% of flowCommon StockSEC:0001567619-22-004545:0
Ideal exit: 7 Nov 2022 (T+270)
17,500 shares@ US$4.650.26% mcap3.1% of flowCommon StockSEC:0001567619-22-002935:0
Ideal exit: 31 Oct 2022 (T+270)
17,500 shares@ US$4.650.26% mcap6.9% of flowCommon StockSEC:0001567619-22-002935
Ideal exit: 31 Oct 2022 (T+270)
6,100 shares@ US$4.310.085% mcap1.0% of flowCommon StockSEC:0001567619-22-002034:0
Ideal exit: 24 Oct 2022 (T+270)
6,100 shares@ US$4.310.085% mcap2.2% of flowCommon StockSEC:0001567619-22-002034
Ideal exit: 24 Oct 2022 (T+270)
20,100 shares@ US$4.860.31% mcap3.7% of flowCommon StockSEC:0001567619-22-001804:0
Ideal exit: 22 Oct 2022 (T+270)
20,100 shares@ US$4.860.31% mcap8.3% of flowCommon StockSEC:0001567619-22-001804
Ideal exit: 22 Oct 2022 (T+270)
24,703 shares@ US$4.940.39% mcap4.7% of flowCommon StockSEC:0001567619-22-001634:0
Ideal exit: 18 Oct 2022 (T+270)
24,703 shares@ US$4.940.39% mcap10.3% of flowCommon StockSEC:0001567619-22-001634
Ideal exit: 18 Oct 2022 (T+270)
10,244 shares@ US$4.970.16% mcap4.3% of flowCommon StockSEC:0001567619-22-001464
Ideal exit: 16 Oct 2022 (T+270)
10,244 shares@ US$4.970.16% mcap1.9% of flowCommon StockSEC:0001567619-22-001464:0
Ideal exit: 16 Oct 2022 (T+270)
10,000 shares@ US$5.080.16% mcap4.3% of flowCommon StockSEC:0001567619-22-001342
Ideal exit: 15 Oct 2022 (T+270)
25 of 48 declarations
About Peyer James
James Peyer is a Board Member at Sensei Biotherapeutics, Inc.
